Cargando…
Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial
BACKGROUND: Coronavirus disease 2019 (COVID-19) is still a pandemic, with a high mortality rate in severe/critical cases. Therapies based on the Shenghuang Granule have proved helpful in viral infection and septic shock. HYPOTHESIS/PURPOSE: The objective of the current study was to compare the effic...
Autores principales: | Zhou, Shuang, Feng, Jun, Xie, Qin, Huang, Tingrong, Xu, Xiaoming, Zhou, Daixing, Zhang, Wen, Sun, Shuting, Liu, Xudong, Wu, Xinxin, Che, Jinhua, Fan, Tian, Zou, Dengxiu, Wang, Junshuai, Zhan, Daqian, Peng, Dan, Feng, Yikuan, Yu, Gang, Yuan, Zuobiao, Fang, Bangjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161732/ https://www.ncbi.nlm.nih.gov/pubmed/34126419 http://dx.doi.org/10.1016/j.phymed.2021.153612 |
Ejemplares similares
-
Clinical Effect of Traditional Chinese Medicine Shenhuang Granule in Critically Ill Patients with COVID-19: A Single-Centered, Retrospective, Observational Study
por: Feng, Jun, et al.
Publicado: (2021) -
Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial
por: Fang, Bangjiang, et al.
Publicado: (2020) -
Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial
por: Zhang, Wen, et al.
Publicado: (2021) -
Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking
por: Xu, Xiang-ru, et al.
Publicado: (2022) -
Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients: A multicenter retrospective cohort study
por: Wu, Xinxin, et al.
Publicado: (2021)